Article

Lenvatinib Improves the Relative Abundance of Probiotics in Intestinal Flora of Patients with Primary Liver Cancer

2024-03-28

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Lenvatinibis commonly used systemic therapeutic drugs for patients with advanced Primary Liver Cancer (PLC). Recent studies have found that gut microbiota can regulate the efficacy of anti-tumor drugs. However, the relationship between antiangiogenic drugs and intestinal flora is not clear, and there is no relevant clinical research. <bold>Methods</bold> We inves...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e27a0224-aad8-50ed-ad04-8d3705fad585
DOI: 10.21203/rs.3.rs-4024621/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Lenvatinib Improves the Relative Abundance of Probiotics in Intestinal Flora of Patients with Primary Liver CancerDOI 10.21203/rs.3.rs-4024621/v1Read

Gut Microbiota as Prognosis Markers for Patients with HBV-Related Acute-on-Chronic Liver FailureSemantic proximity Read

Relationship between Intestinal Microflora and Hepatocellular Cancer Based on Gut‐Liver Axis TheorySemantic proximity Read

Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failureSemantic proximity Read

The gut microbiota modulates responses to anti–PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumorsSemantic proximity Read

Gut microbial profile of treatment-naive patients with primary biliary cholangitisSemantic proximity Read

Correlation analysis for alterations of intestinal flora in hepatocellular carcinoma patients: combinatorial detection of Coriobacterium, Atopobium, Coprococcus and Veillonella dispar may be a new method for HCC diagnosisSemantic proximity Read

Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot studySemantic proximity Read

Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventionsSemantic proximity Read

Correlation of Gut Microbiota with Efficacy of Chemotherapy in Patients with Diffuse Large B-cell LymphomaSemantic proximity Read

Gut microbial profile of treatment-naive patients with primary biliary cholangitisSemantic proximity Read

Gut Microbiota Shifts from Onset to Remission in Immune Checkpoint Inhibitor-Induced Enterocolitis: A Case ReportSemantic proximity Read

A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinomaSemantic proximity Read